chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I feel tired; Arm is still swollen; Spitted and saw blood; Choking; Coughing; Red arm; A spontaneous report was received from a consumer concerning a 66-year-old, female patient, who experienced choking, coughing, spitted blood/hemoptysis, fatigue, arm redness/injection site erythema and swelling of arm/injection site swelling.    The patient's medical history was not provided. Concomitant products known to have been used by the patient, within two weeks prior to the events were atorvastatin, aspirin, Lipitor, water pills and vitamin D3.  On 26 Jan 2021, the patient received their first of two planned doses of mRNA-1273 (Lot number: 028L20A) in the left non-dominant arm for prophylaxis of COVID-19 infection. On 23 Feb 2021, the patient received their second of two planned doses of Mrna-1273 (Lot number: 012M20A) in the left non- dominant arm for prophylaxis of COVID-19 infection.   After the second dose, the patient experienced arm redness. On 25 Feb 2021, the patient experienced choking, coughing and spitted out blood, which was experienced on 26 Feb 2021 morning as well. Later, on 26 Feb 2021 the patient developed swollen and reddish arm and fatigue. No such symptoms were experienced after first dose.   Treatment  for the event was not provided.  Action taken with mRNA-1273 in response to the events was not applicable.   The outcome of the events, choking, cough, hemoptysis, fatigue, injection site erythema and injection site swelling were unknown.; Reporter's Comments: Very limited information regarding this event/s has been provided at this time.  Further information has been requested.
Right thigh became tender to touch 1 day after IM injection. Swelling started to worsen on day 2 after injection up until initial treatment on Oct. 22. Swelling did not decrease until 10/24/16.
Information has been received from a licensed practical nurse referring to multiple unspecified patients of unknown age and gender. Information regarding concomitant medication, medical history and drug reactions/allergies was not reported. On unknown dates, the patients might have received doses of improperly stored RECOMBIVAX HB (lot # L038018 with expiration date 13-SEP-2017; dose and route were not reported). The vaccine was exposed to 31 Fahrenheit for 40 minutes. There was no prior excursion. Data logger was unknown. No adverse effects were reported. At the reporting time, the reporter did not sure if the vaccine was administered. This is one of several reports received from the same reporter. Additional information has been requested.
Some people's arms hurt after receiving a dose; In bed sick like the flu; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Some people's arms hurt after receiving a dose) and ILLNESS (In bed sick like the flu) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Some people's arms hurt after receiving a dose) and ILLNESS (In bed sick like the flu). At the time of the report, PAIN IN EXTREMITY (Some people's arms hurt after receiving a dose) and ILLNESS (In bed sick like the flu) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided. Treatment information was not provided.
The pt came in on 12/14/01. States she broke out 4-5 days, post vax of MMR and went to ER and got no treatment. Went back to ER on 10/25/01 and was dx'd with hives and given a "shot" and prescription for Atarax 25mg.
gave Bexsero last year, 70 years old.; This case was reported by a consumer via call center representative and described the occurrence of inappropriate age at vaccine administration in a 70-year-old female patient who received Men B NVS (Bexsero) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   On an unknown date, the patient received Bexsero and Bexsero Pre-Filled Syringe Device. On an unknown date, unknown after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 25-OCT-2022 Reporter's Comment:  Reporter reported that her HCP gave her Bexsero last year and she is 70 years old (at the time of reporting). No additional demographics collected.  Did not consent to follow-up. Caller did not give permission to contact HCP. Additional supportive information: As patient received Bexsero at an inappropriate age which led to inappropriate age at vaccine administration.
Deep pain in large muscles after any activity,, ASA does relieve it but would rather not take it.
Information has been received from a registered nurse concerning a 77 year old female patient with ULTRAM and PENICILLIN allergy, who in 1998 was vaccinated with the first dose of PNEUMOVAX, 0.5ml, intramuscularly;  in October 2008, was vaccinated with the second dose of PNEUMOVAX, 0.5ml, intramuscularly and on 24-FEB-2009, was inadvertently vaccinated with a third dose of PNEUMOVAX, 0.5ml, intramuscularly (Lot # /0982X).  Concomitant therapy included SIMVASTATIN (manufacturer unknown), levothyroxine Na, DIAZIDE and baby ASPIRIN.  The nurse reported  that on 24-FEB-2009, the patient experienced redness and pain at the injection site.  It was noted that the redness and pain began at the injection site and extended towards the elbow.  The patient sought medical attention and was seen at the physician's office.  At the time of the report, the patient had not recovered.  Additional information has been requested.
body aches; when you touch his arm or chest it feels like his muscles hurt and just touching the skin hurts; fatigued; when you touch his arm or chest it feels like his muscles hurt and just touching the skin hurts; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 31Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN (non-serious) with onset 2021, outcome "unknown", described as "body aches"; PAIN OF SKIN (non-serious), MYALGIA (non-serious) all with onset 2021, outcome "unknown" and all described as "when you touch his arm or chest it feels like his muscles hurt and just touching the skin hurts"; FATIGUE (non-serious) with onset 2021, outcome "unknown", described as "fatigued".  Additional information: The reporter stated that he had the first dose of the vaccine yesterday and feels fatigued and has body aches. He stated that when you touch his arm or chest it feels like his muscles hurt and just touching the skin hurts. He has been aching all night. He asked if this is normal? The reporter asked how long should side effects last? How long is too long for side effects to last? also asked if he should still wear a mask after getting the vaccine? Stated he is going to work tomorrow and asked if he can he give his coworkers Covid after getting the vaccine? He stated he will still be wearing a mask and social distancing. His question was less in regard to whether he is protected but more in regards to if he could get people sick from the vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
"Is that any side effects?" - Experiencing side effects? "Yes, it's correct"; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION COMPLICATION ("Is that any side effects?" - Experiencing side effects? "Yes, it's correct") in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION ("Is that any side effects?" - Experiencing side effects? "Yes, it's correct"). At the time of the report, VACCINATION COMPLICATION ("Is that any side effects?" - Experiencing side effects? "Yes, it's correct") outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
been seriously ill for 3 weeks; I got sick until I got conjunctivitis; conjunctivitis; Initial information received on 15-Dec-2022 regarding an unsolicited valid social media non-serious case received from a consumer/non-hcp.  This case involves an unknown age and unknown gender patient who experienced been seriously ill for 3 weeks; I got sick until I got conjunctivitis and conjunctivitis while receiving vaccine influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect influenza vaccine produced by unknown manufacturer (strength, formulation, dose, expiration date and lot number not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date the patient developed a non-serious been seriously ill for 3 weeks; i got sick until i got conjunctivitis (illness) and conjunctivitis (conjunctivitis) (unknown latency).  Lab data was not reported.  Action taken was not applicable.  corrective treatment was not reported for both the events.  Outcome was Unknown for both the events.
Flu symptoms (chills, fever, body aches, headache, fatigue) began about 12 hours after vaccine received.  This was the second vaccine in the 2-part series.  Flu symptoms were severe enough to miss work for a day and feel unwell for about 48 hours.   After the flu symptoms passed, I had GI issues for about two weeks - upset stomach, nausea (no vomiting), gas.  Symptoms evenually resolved after about 2 and a half weeks.
Acute lymphadenitis- supraclavicular lymph nodes on left side (same side where vaccine was injected) and a 4cm welt on chest was noted with itching.
headache; very mild fever; severe body ache; severe nausea; fatigue; splitting headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), PYREXIA (very mild fever), MYALGIA (severe body ache), NAUSEA (severe nausea) and FATIGUE (fatigue) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003B21A and 047B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Chronic fatigue, Bowel obstruction and Digestion impaired.   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Mar-2021, the patient experienced HEADACHE (headache), PYREXIA (very mild fever), MYALGIA (severe body ache), NAUSEA (severe nausea), FATIGUE (fatigue) and HEADACHE (splitting headache). At the time of the report, HEADACHE (headache), PYREXIA (very mild fever), MYALGIA (severe body ache), NAUSEA (severe nausea), FATIGUE (fatigue) and HEADACHE (splitting headache) outcome was unknown. Not Provided          No concomitant medication was reported. No treatment medication was reported.   This case was linked to MOD-2021-106954 (Patient Link).
Fully vaccinated person became symptomatic for COVID-19 on 8/23/21 and tested positive on 8/23/21.
The day of vaccination patient experienced flu-like symptoms including: headache, low grade fever, and tiredness. She called 3 days later stating that she now has a rash on her stomach, both arms, and both thighs. She no longer has the flu-like symptoms, just the tiredness. Suggested she take CLARITIN for allergy symptoms.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 10-MAR-2015 the patient was vaccinated with an improperly stored dose of RECOMBIVAX HB 5 microgram/0.5 mL (lot # H017304, expiration date 11-JUL-2015, dose and route were unknown). No adverse effects were reported. The vaccine was exposed to temperature excursion once. The total cumulative excursion time was 16 hours. The lowest recorded temperature was 33 Celsius degree. The storage criteria of the vaccine and the type of excursion were refrigerator (R). This is one of several reports received from the same source. Additional information has been requested.
Started getting really congested and run down. Took home COVID-19 test and was positive. Was prescribed PAXLOVID and took EMERGEN-C dietary supplement. Took another home COVID-19 test and was negative 1 week later.
pt recvd vax; high pitched persistent crying more than 3 hrs; swelling, redness at site;
Patient's husband reported that his wife's arm started to get a rash around the injection sites. Her arm was sore, sensitive to touch. They waited a couple of days thinking it would go away. The rash started to spread and they decided to go get it checked out. The husband reported that hospital said there was an infection and thus the patient being prescribed antibiotics on 12/15/18 (three days after the vaccinations).
Fever 101.8 on 11/11/2021 Redness and swelling at injection site going down from shoulder almost to elbow, stiffness on11/12/2021 Rash and itchy from shoulder to elbow, swollen, 11/13/2021
I was recovering from a bout with SHINGLES ans the blister area and pain was healing. I was advised by my doctor to get vaccinated against future recurrences with SHINGRIX. My 1st dose of Shingrix Shingles vaccine caused a recurrence of shingles and postherpetic neuralgia (PHN). My doctor advised waiting before receiving a 2nd dose. Still experiencing PHN (mild)
Patient had complleted her 30 mintues of  observation due to her history of multiples allergies. She had left the building and went to her car when she developed facial flushing and was concerned about an allergic reaction so she presented back to the facility for evaluation. Her blood pressure was 152/98 with recheck 190/108. Hr 80s with pulse ox 100% on room air. She has a ast medical history significant for asthma and hypertension. Benadryl 25 mg was given and Paramedics were on site and took over care. She was stable at time of transfer to the hospital.
product was given to a patient after it had expired with no reported adverse event; Initial information received on 17-Oct-2023 regarding an unsolicited valid  non-serious case received from a health professional.  This case involves an unknown age and unknown gender patient who experienced product was given to a patient after it had expired with no reported adverse event, after receiving vaccine Hib (Prp/T) Vaccine [Act-Hib].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect Hib (Prp/T) Vaccine, Powder and solvent for solution for injection, (strength: unknown) (lot number, expiry date: not reported) via unknown route in unknown administration site for immunization.  On an unknown date the product was given to a patient after it had expired, with no reported adverse event (expired product administered) (latency: same day) following the administration of Hib (Prp/T) Vaccine.  Action taken: not applicable.  At time of reporting, the outcome was Unknown for the event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive and Regulatory Authority Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
left deltoid raised red 4" across arm and 1.5 " high itchy (very).  Warm to touch,  today getting larger and as not as red, warm to touch.   will contact dr if starts to get larger.
PATIENT HAD LIP AND TONGUE SWELLING AFTER PFIZER VACCINE. SYMPTOMS STARTED AFTER 10MINUTES. ONE DOSE OF EPIPEN WAS ADMINISTERED AT PHARMACY. PATIENT WAS ALSO GIVEN 25MG OF DIPHENHYDRAMINE.
Pt called hospital call ceneter to report side effects with booster pfizer dose.  w/o injection site pain, fatigue, and mild lymph node swelling. per pt sxs improve the past few days. Has been taking tylenol PRN.  No ER s/sxs at the time of call.   Pt advised to monitor and to f/u with PCP if symptoms not improving.
Prostate pain, initially 2/10 beginning 3 days after first dose, increasing to 6/10 within approximately 8-10 hours after receiving second dose on 8 Nov 2021. No past history of prostate pain or prostate problems prior to this event. Treated with antibiotics (Cipro and Bactrim) with some relief initially, but pain returned after or during antibiotic courses. Pain mostly resolved while on Meloxicam, but has returned intermittently while not on medication. Pain still persistent (1/10) at time of this report, 14 July 22.
I found out about the adverse event on Friday night, October 5, 2018 after the patient filed a complaint. She stated that her arm was inflamed and had a yellowish color around the bottom rim of inflammation on her arm. She was given the shot on Tuesday, October 2, 2018 and I believe she started having a reaction later that day. She came in with her husband on Thursday, October 4, 2018 as he was getting a PREVNAR shot and flu shot. She showed my staff pharmacist her arm as they were leaving. My staff pharmacist stated that she did not think it was a typical reaction and urged the patient to see her doctor. My pharmacist told me it looked like inflammation with liquid. I believe the patient was either seen by her doctor later that day or the following day. She stated that the doctor believed that I did not clean the area very well and therefore introduced bacteria, thereby causing an infection. She said she was given an antibiotic and steroid and told to finish the course before it turned into MRSA. I'm unsure what lab tests or cultures were done, if any. I am also unsure which medications she was given as we did not fill the prescriptions at my pharmacy. The PNEUMOVAX was the only prescription on her profile after checking. I did apologize for what she experienced and told her it was the first time anyone has had a reaction since I had been giving immunizations starting 2009. I also told her I would file a report and follow up. I contacted later that evening, our third party who handles claims. After speaking in further detail on Monday, October 8, with the rep they said they would follow up with the patient and handle any claims she may have. I was also told not to contact the patient further as they would be the one to follow up.
Information has been received from a nurse on 11-FEB-2015 referring to a patient of unknown age. On 20-JAN-2015 the patient was vaccinated with a dose of VARIVAX (Merck) injection, 0.5 ml, subcutaneously (lot# was not reported) which underwent a temperature excursion. No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested.
no adverse event; All doses were given at a 0.2mL dosage from the presentation with the dark pink cap with yellow border instead of the dark blue cap and label with gray border presentation; This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (All doses were given at a 0.2mL dosage from the presentation with the dark pink cap with yellow border instead of the dark blue cap and label with gray border presentation) and NO ADVERSE EVENT (no adverse event) in a child patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 215K22A) for COVID-19 prophylaxis.     No Medical History information was reported.    In April 2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .2 milliliter. In April 2023, the patient experienced WRONG PRODUCT ADMINISTERED (All doses were given at a 0.2mL dosage from the presentation with the dark pink cap with yellow border instead of the dark blue cap and label with gray border presentation). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (All doses were given at a 0.2mL dosage from the presentation with the dark pink cap with yellow border instead of the dark blue cap and label with gray border presentation) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (All doses were given at a 0.2mL dosage from the presentation with the dark pink cap with yellow border instead of the dark blue cap and label with gray border presentation).    No concomitant medications were provided. Doses were administered from 24-Apr-2023 to 28-Apr-2023. Patients between 6m-5y of age were involved.  No reported symptoms. No treatment medication was provided. This case contains information for the 8th of 12 child patients described by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-722123 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-722123:1st patient case (Master case)
Was not feeling well and passed out, spouse took her to hospitalized was admitted from Nov. 15-18/2021; On the Nov. 18, 2021 AFIB then was shocked back into heart rhythm. Then on 11/19/2021 ER by ambulance and was admitted to hospital again from 12/03/-12/10/2021. Then went back into 12/20/2021 AFIB then was shocked back into rhythm. Returned to hospital on 12/15-21, 2021. Scheduled for 03/21/2022 for pacemaker and this is the new health issue.
My COVID-19 infection symptoms started on 12/23/2022 in the morning . I tested positive with a COVID-19 home test on 12/23/2022. I  had headaches and I was exhausted since I had a hip surgery. I was very mobile. Everyone in the house tested positive for COVID-19 infection I also tested  positive as well. After testing  I called my doctor's office and the nurse prescribe me with Anti-viral for 5 days. I was feeling better after the 2nd pill.
102.8 fever, chills, muscle aches, nausea, fatigue and soreness at injection site for 36 hours.  After symptoms ended, I developed a mild rash at the injection site and everything I ate or drank tasted like metal. This lasted for about 12 hours then improved.
Vaccinated 4/28/14 with MMR after negative rubella titer of 4/17/14. 5/14 Developed ache in both hands and (R) ankle. 5/23 Ache and numbness intermittent persists in both hands.